Clinical Trials Browser

Phase 2 × Biliary Tract Neoplasms × sintilimab × Clear all

NCT04300959 2020-03-09

Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer

Phase 2 Unknown

Gastrointestinal

Biliary Tract Neoplasms